Protara Therapeutics, Inc. (TARA) Tops Q3 EPS by 29c

Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q3 EPS of ($0.68), $0.29 better than the analyst estimate of ($0.97).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery